You will find all our regulatory press releases in the feed below. Enjoy and share all our other Asarina Pharma news in our regularly updated News Archive.
(Stockholm May 20, 2019) Asarina Pharma CEO Peter Nordkild: “We have made a strong start to 2019. This Quarter we have strengthened our team and capabilities, yet still maintained strict financial management – leading to a solid cash position at the end of the First Quarter.”
Full PDF(Stockholm May 8, 2019) On 8 May 2019, the Annual General Meeting (”AGM”) of Asarina Pharma AB (publ) was held in Stockholm. Read below for a summary of the decisions made.
Full PDF(Stockholm April 17 2019) Asarina Pharma AB today announces that its Annual Report for 2018 is now available on the company’s website.
Full PDF(April 11 2019) The following proposals (items 12-15 in the agenda) for the upcoming Annual General Meeting have been made:
Full PDFThe shareholders of Asarina Pharma AB (publ) are hereby summoned to attend the Annual General Meeting (“AGM”) on May 8th, 2019, at 15.00 CET at Erik Penser Bank, Apelbergsgatan 27 in Stockholm, Sweden. Registration starts at 14.30 CET and will stop when the meeting starts. NOTE: This is an unofficial translation of the original notice,…
Full PDF